Skip to main content
Erschienen in: Head and Neck Pathology 4/2022

03.08.2022 | Review

Clinical, Radiographic and Histopathological Analysis of Craniopharyngiomas and Ameloblastomas: A Systematic Review

verfasst von: Luana Amorim Morais da Silva, Solimar Ribeiro Carlete Filho, Marcelo Jales Diniz Saraiva, Caio Rodrigues Maia, Camila Dannyelle Fernandes Dutra Pereira Santos, Pedro Paulo de Andrade Santos

Erschienen in: Head and Neck Pathology | Ausgabe 4/2022

Einloggen, um Zugang zu erhalten

Abstract

Background

Craniopharyngiomas and ameloblastomas are tumors of epithelial origin, mostly characterized by a benign course, slow growth and for being locally invasive. Some studies highlight the similarity of these neoplasms, especially regarding histopathological aspects. In this context, the aim of the present study was to carry out a systematic literature review correlating the clinical, radiographic, and histopathological aspects of these two tumors.

Methods

Searches were conducted at the Pubmed, Periódicos Capes, Scopus, Science Direct, Web of Science and Scielo databases, according to the following inclusion criteria: publications in English or Spanish, from the 2000s and 2021, comprising case report studies, case series and literature reviews.

Results

Considering clinical and radiographic aspects, it is evident that craniopharyngiomas and ameloblastomas exhibit few similarities. Histopathologically, however, adamantinomatous craniopharyngiomas are the type of tumor that most resembles ameloblastomas, both concerning the formation of palisade epithelial cords and epithelial formations. Regarding to recurrences in cases of craniopharyngioma, it appears that a more radical surgical resection is more related to a lower recurrence rate for both craniopharyngiomas and ameloblastomas. As for the outcome, it was observed that craniopharyngiomas have a greater relationship with possible systemic disorders.

Conclusions

This histopathological similarity is related to their origin, since both craniopharyngiomas and ameloblastomas share a relationship with the oral cavity, either partially, as in the case of craniopharyngiomas, or totally, as in ameloblastomas, not comprising the same lesion in different locations. It is important to note that the differential morphogenetic evidence observed herein between these lesions opens up a new field of study aiming at better treatment alternatives in the future.
Literatur
1.
Zurück zum Zitat Müller H, Merchant T, Warmuth-Metz M, Martinez-Barbera JP, Puget S. Craniopharyngioma. Nat Rev Dis Primers. 2019; 5(1). Müller H, Merchant T, Warmuth-Metz M, Martinez-Barbera JP, Puget S. Craniopharyngioma. Nat Rev Dis Primers. 2019; 5(1).
2.
Zurück zum Zitat Kiliç M, Can S, Özdemir B, Tanik C. Management of Craniopharyngioma. J Craniofac Surg. 2019;30(2):e178–83.CrossRef Kiliç M, Can S, Özdemir B, Tanik C. Management of Craniopharyngioma. J Craniofac Surg. 2019;30(2):e178–83.CrossRef
3.
Zurück zum Zitat Badger K, Gardner D. The relationship of adamantinomatous craniopharyngioma to ghost cell ameloblastoma of the jaws: a histopathologic and immunohistochemical study. J Oral Pathol Med. 1997;26(8):349–55.CrossRef Badger K, Gardner D. The relationship of adamantinomatous craniopharyngioma to ghost cell ameloblastoma of the jaws: a histopathologic and immunohistochemical study. J Oral Pathol Med. 1997;26(8):349–55.CrossRef
4.
Zurück zum Zitat Masthan K, Anitha K, Krupaa J, Manikkam S. Ameloblastoma. J Pharm Bioallied Sci. 2015;7(1):167-70. Masthan K, Anitha K, Krupaa J, Manikkam S. Ameloblastoma. J Pharm Bioallied Sci. 2015;7(1):167-70.
5.
Zurück zum Zitat Adeel M, Rajput M, Arain A. Ameloblastoma: Management and Outcome. Cureus. 2018;10(10):e3437. Adeel M, Rajput M, Arain A. Ameloblastoma: Management and Outcome. Cureus. 2018;10(10):e3437.
6.
Zurück zum Zitat Evangelou Z, Zarachi A, Dumollard J. Maxillary Ameloblastoma: A Review With Clinical, Histological and Prognostic Data of a Rare Tumor. Vivo. 2020;34(5):2249–58.CrossRef Evangelou Z, Zarachi A, Dumollard J. Maxillary Ameloblastoma: A Review With Clinical, Histological and Prognostic Data of a Rare Tumor. Vivo. 2020;34(5):2249–58.CrossRef
7.
Zurück zum Zitat Falavigna A, Kraemer J. Infrasellar craniopharyngioma: case report. Arq Neuropsiquiatr. 2001;59(2B):424–30.CrossRef Falavigna A, Kraemer J. Infrasellar craniopharyngioma: case report. Arq Neuropsiquiatr. 2001;59(2B):424–30.CrossRef
8.
Zurück zum Zitat Deutsch H, Kothbauer K, Persky M, Epstein F, Jallo G. Infrasellar Craniopharyngiomas: Case Report and Review of the Literature. Skull Base. 2001;11(2):121–8.CrossRef Deutsch H, Kothbauer K, Persky M, Epstein F, Jallo G. Infrasellar Craniopharyngiomas: Case Report and Review of the Literature. Skull Base. 2001;11(2):121–8.CrossRef
9.
Zurück zum Zitat Yamini B, Narayanan M. Craniopharyngiomas: an update. Expert Rev Anticancer Ther. 2006;6(1):85–92.CrossRef Yamini B, Narayanan M. Craniopharyngiomas: an update. Expert Rev Anticancer Ther. 2006;6(1):85–92.CrossRef
10.
Zurück zum Zitat Krishnapillai R, Angadi P. A clinical, radiographic, and histologic review of 73 cases of ameloblastoma in an Indian population. Quintessence Int. 2010;41(5):e90–100. Krishnapillai R, Angadi P. A clinical, radiographic, and histologic review of 73 cases of ameloblastoma in an Indian population. Quintessence Int. 2010;41(5):e90–100.
11.
Zurück zum Zitat Fregnani ER, da Cruz Perez DE, de Almeida OP, et al. Clinicopathological study and treatment outcomes of 121 cases of ameloblastomas. Int J Oral Maxillofac Surg. 2010;39:145–9.CrossRef Fregnani ER, da Cruz Perez DE, de Almeida OP, et al. Clinicopathological study and treatment outcomes of 121 cases of ameloblastomas. Int J Oral Maxillofac Surg. 2010;39:145–9.CrossRef
12.
Zurück zum Zitat Magill J, Ferguson M, Sandison A, Clarke P. Nasal craniopharyngioma: case report and literature review. J Laryngol Otol. 2011;125(05):517–9.CrossRef Magill J, Ferguson M, Sandison A, Clarke P. Nasal craniopharyngioma: case report and literature review. J Laryngol Otol. 2011;125(05):517–9.CrossRef
13.
Zurück zum Zitat Gao S, Shi X, Wang Y, Qian H, Liu C. Malignant transformation of craniopharyngioma: case report and review of the literature. J Neurooncol. 2011;103(3):719–25.CrossRef Gao S, Shi X, Wang Y, Qian H, Liu C. Malignant transformation of craniopharyngioma: case report and review of the literature. J Neurooncol. 2011;103(3):719–25.CrossRef
14.
Zurück zum Zitat Lee S, Kim Y. Current Concepts and Occurrence of Epithelial Odontogenic Tumors: I. Ameloblastoma and Adenomatoid Odontogenic Tumor. Korean J Pathol. 2013;47(3):191–202.CrossRef Lee S, Kim Y. Current Concepts and Occurrence of Epithelial Odontogenic Tumors: I. Ameloblastoma and Adenomatoid Odontogenic Tumor. Korean J Pathol. 2013;47(3):191–202.CrossRef
15.
Zurück zum Zitat Nair P, Bhat G, Neelakantan S. Desmoplastic ameloblastoma of mandible. BMJ Case Rep. 2013; 2013: bcr2013200082. Nair P, Bhat G, Neelakantan S. Desmoplastic ameloblastoma of mandible. BMJ Case Rep. 2013; 2013: bcr2013200082.
16.
Zurück zum Zitat Gloria J. Extragnathic Sinonasal Ameloblastoma: A Rare Benign Intranasal Tumor with Malignant Features. Philipp J Otolaryngol Head Neck Surg. 2013;28(1):19–23.CrossRef Gloria J. Extragnathic Sinonasal Ameloblastoma: A Rare Benign Intranasal Tumor with Malignant Features. Philipp J Otolaryngol Head Neck Surg. 2013;28(1):19–23.CrossRef
17.
Zurück zum Zitat Bansal S, Desai R, Shirsat P. The occurrence and pattern of ameloblastoma in children and adolescents: an Indian institutional study of 41 years and review of the literature. Int J Oral Maxillofac Surg. 2015;44(6):725–31.CrossRef Bansal S, Desai R, Shirsat P. The occurrence and pattern of ameloblastoma in children and adolescents: an Indian institutional study of 41 years and review of the literature. Int J Oral Maxillofac Surg. 2015;44(6):725–31.CrossRef
18.
Zurück zum Zitat Milman T, Ying GS, Pan W, LiVolsi V. Ameloblastoma: 25 Year Experience at a Single Institution. Head Neck Pathol. 2016;10:513–20.CrossRef Milman T, Ying GS, Pan W, LiVolsi V. Ameloblastoma: 25 Year Experience at a Single Institution. Head Neck Pathol. 2016;10:513–20.CrossRef
19.
Zurück zum Zitat Okada T, Fujitsu K, Ichikawa T, et al. Unicystic Ameloblastoma Cystic Craniopharyngioma: Pathological Discussion and Clinical Significance of Cyst Formation in Adamantinomatous Craniopharyngioma. Pediatr Neurosurg. 2016;51(3):158–63.CrossRef Okada T, Fujitsu K, Ichikawa T, et al. Unicystic Ameloblastoma Cystic Craniopharyngioma: Pathological Discussion and Clinical Significance of Cyst Formation in Adamantinomatous Craniopharyngioma. Pediatr Neurosurg. 2016;51(3):158–63.CrossRef
20.
Zurück zum Zitat Adeel M, Rajput MSA, Arain AA, Baloch M, Khan M. Ameloblastoma: Management and Outcome. Cureus. 2018;10(10):e3437. Adeel M, Rajput MSA, Arain AA, Baloch M, Khan M. Ameloblastoma: Management and Outcome. Cureus. 2018;10(10):e3437.
21.
Zurück zum Zitat Omay SB, Chen YN, Almeida JP, et al. Do craniopharyngioma molecular signatures correlate with clinical characteristics? J Neurosurg. 2018;128:1473–8.CrossRef Omay SB, Chen YN, Almeida JP, et al. Do craniopharyngioma molecular signatures correlate with clinical characteristics? J Neurosurg. 2018;128:1473–8.CrossRef
22.
Zurück zum Zitat Drapeau A, Walzm C, Eide J, et al. Pediatric craniopharyngioma. Child Nerv Syst. 2019;35(11):2133–45.CrossRef Drapeau A, Walzm C, Eide J, et al. Pediatric craniopharyngioma. Child Nerv Syst. 2019;35(11):2133–45.CrossRef
23.
Zurück zum Zitat Mende KC, Kellner T, Petersenn S, et al. Clinical Situation, Therapy, and Follow-Up of Adult Craniopharyngioma Report from the German Craniopharyngioma Registry. J Clin Endocrinol Metab. 2020;105(1):252–65.CrossRef Mende KC, Kellner T, Petersenn S, et al. Clinical Situation, Therapy, and Follow-Up of Adult Craniopharyngioma Report from the German Craniopharyngioma Registry. J Clin Endocrinol Metab. 2020;105(1):252–65.CrossRef
24.
Zurück zum Zitat Sharma A, Ingole S, Deshpande M. Retrospective analysis of Desmoplastic Ameloblastoma: Clinical review. Med Oral Patol Oral Cir Bucal. 2021;26(2):e246–55.CrossRef Sharma A, Ingole S, Deshpande M. Retrospective analysis of Desmoplastic Ameloblastoma: Clinical review. Med Oral Patol Oral Cir Bucal. 2021;26(2):e246–55.CrossRef
25.
Zurück zum Zitat Fugio S, Juratli TA, Takajo T, et al. Craniopharyngiomas, including Recurrent Cases, Lack TERT Promoter Hotspot Mutations. Neurol Med Chir (Tokyo). 2021;61:385–91.CrossRef Fugio S, Juratli TA, Takajo T, et al. Craniopharyngiomas, including Recurrent Cases, Lack TERT Promoter Hotspot Mutations. Neurol Med Chir (Tokyo). 2021;61:385–91.CrossRef
26.
Zurück zum Zitat Hresko A, Burtyn O, Pavlovskiy L, et al. Controversies in ameloblastoma management: evaluation of decision making, based on a retrospective analysis. Med Oral Patol Oral Cir Bucal. 2021;26(2):e181–6.CrossRef Hresko A, Burtyn O, Pavlovskiy L, et al. Controversies in ameloblastoma management: evaluation of decision making, based on a retrospective analysis. Med Oral Patol Oral Cir Bucal. 2021;26(2):e181–6.CrossRef
27.
Zurück zum Zitat Kopparapu S, Khalafallah AM, Botros D, et al. Predictors of Postoperative Visual Outcome After Surgical Intervention for Craniopharyngiomas. World Neurosurg. 2021;148:e589–99.CrossRef Kopparapu S, Khalafallah AM, Botros D, et al. Predictors of Postoperative Visual Outcome After Surgical Intervention for Craniopharyngiomas. World Neurosurg. 2021;148:e589–99.CrossRef
28.
29.
Zurück zum Zitat Garnett M, Puget S, Grill J, Sainte-Rose C, Craniopharyngioma. Orphanet J Rare Dis. 2007;2(1):18.CrossRef Garnett M, Puget S, Grill J, Sainte-Rose C, Craniopharyngioma. Orphanet J Rare Dis. 2007;2(1):18.CrossRef
30.
Zurück zum Zitat Larkin S, Ansorge O. Pathology and pathogenesis of craniopharyngiomas. Pituitary. 2013;16:9–17.CrossRef Larkin S, Ansorge O. Pathology and pathogenesis of craniopharyngiomas. Pituitary. 2013;16:9–17.CrossRef
31.
Zurück zum Zitat Burger P, Scheithayer B. Tumors of the central nervous system. Atlas of Tumor Pathology, 1994, p 349–69. Armed Forces Institute of Pathology, Washington, DC. Burger P, Scheithayer B. Tumors of the central nervous system. Atlas of Tumor Pathology, 1994, p 349–69. Armed Forces Institute of Pathology, Washington, DC.
32.
Zurück zum Zitat Petito C, DeGirolami U, Earle K. Craniopharyngiomas. A clinical and pathological review. Cancer. 1976;37:1944–52.CrossRef Petito C, DeGirolami U, Earle K. Craniopharyngiomas. A clinical and pathological review. Cancer. 1976;37:1944–52.CrossRef
33.
Zurück zum Zitat WHO Classification of Head and Neck Tumours. In. El-Naggar A, Chan JKC, Grandis JR et al, editors Lyon, France: IARC Press; 2017. WHO Classification of Head and Neck Tumours. In. El-Naggar A, Chan JKC, Grandis JR et al, editors Lyon, France: IARC Press; 2017.
34.
Zurück zum Zitat Apps JR, Carreno G, Gonzalez-Meljem JM, et al. Tumour compartment transcriptomics demonstrates the activation of inflammatory and odontogenic programmes in human adamantinomatous craniopharyngioma and identifies the MAPK/ERK pathway as a novel therapeutic target. Acta Neuropathol. 2018;135:757–77.CrossRef Apps JR, Carreno G, Gonzalez-Meljem JM, et al. Tumour compartment transcriptomics demonstrates the activation of inflammatory and odontogenic programmes in human adamantinomatous craniopharyngioma and identifies the MAPK/ERK pathway as a novel therapeutic target. Acta Neuropathol. 2018;135:757–77.CrossRef
35.
Zurück zum Zitat Kato K, Nakatani Y, Kanno H, et al. Possible linkage between specific histological structures and aberrant reactivation of the Wnt pathway in adamantinomatous craniopharyngioma. J Pathol. 2004;203:814–82.CrossRef Kato K, Nakatani Y, Kanno H, et al. Possible linkage between specific histological structures and aberrant reactivation of the Wnt pathway in adamantinomatous craniopharyngioma. J Pathol. 2004;203:814–82.CrossRef
36.
Zurück zum Zitat Tateyama H, Tada T, Okabe M, Takahashi E, Eimoto T. Different keratin profiles in craniopharyngioma subtypes and ameloblastomas. Pathol Res Pract. 2001;197(11):735–42.CrossRef Tateyama H, Tada T, Okabe M, Takahashi E, Eimoto T. Different keratin profiles in craniopharyngioma subtypes and ameloblastomas. Pathol Res Pract. 2001;197(11):735–42.CrossRef
37.
Zurück zum Zitat Adamson TE, Wistler OD, Kleihues P, Yasargil MG. Correlation of clinical and pathological features in surgically treated craniopharyngiomas. J Neurosurg. 1990;73:12–7.CrossRef Adamson TE, Wistler OD, Kleihues P, Yasargil MG. Correlation of clinical and pathological features in surgically treated craniopharyngiomas. J Neurosurg. 1990;73:12–7.CrossRef
38.
Zurück zum Zitat Crotty T, Scheithauer B, Young JR, et al. Pappilary craniopharyngioma: a clinicopathological study of 48 cases. J Neurosurg. 1995;83:206–14.CrossRef Crotty T, Scheithauer B, Young JR, et al. Pappilary craniopharyngioma: a clinicopathological study of 48 cases. J Neurosurg. 1995;83:206–14.CrossRef
39.
Zurück zum Zitat Hetelekids S, Barnes P, Tao M, et al. 20-year experience in childhood craniopharyngiomas. Int J Radiat Oncol Biol Phys. 1993;27:189–95.CrossRef Hetelekids S, Barnes P, Tao M, et al. 20-year experience in childhood craniopharyngiomas. Int J Radiat Oncol Biol Phys. 1993;27:189–95.CrossRef
40.
Zurück zum Zitat Dias CD, Brandão TB, Soares FA, Lourenço SV. Ameloblastomas: clinical-histopathological evaluation of 85 cases with emphasis on squamous metaplasia and keratinization aspects. Acta Odontol Scand. 2013;71(6):1651–5.CrossRef Dias CD, Brandão TB, Soares FA, Lourenço SV. Ameloblastomas: clinical-histopathological evaluation of 85 cases with emphasis on squamous metaplasia and keratinization aspects. Acta Odontol Scand. 2013;71(6):1651–5.CrossRef
41.
Zurück zum Zitat Gomes CC, Sousa SF, Gomez RS. Craniopharyngiomas and odontogenic tumors mimic normal odontogenesis and share genetic mutations, histopathologic features, and molecular pathways activation. Oral Surg Oral Med Oral Pathol Oral Radiol. 2019;127:231–6.CrossRef Gomes CC, Sousa SF, Gomez RS. Craniopharyngiomas and odontogenic tumors mimic normal odontogenesis and share genetic mutations, histopathologic features, and molecular pathways activation. Oral Surg Oral Med Oral Pathol Oral Radiol. 2019;127:231–6.CrossRef
Metadaten
Titel
Clinical, Radiographic and Histopathological Analysis of Craniopharyngiomas and Ameloblastomas: A Systematic Review
verfasst von
Luana Amorim Morais da Silva
Solimar Ribeiro Carlete Filho
Marcelo Jales Diniz Saraiva
Caio Rodrigues Maia
Camila Dannyelle Fernandes Dutra Pereira Santos
Pedro Paulo de Andrade Santos
Publikationsdatum
03.08.2022
Verlag
Springer US
Erschienen in
Head and Neck Pathology / Ausgabe 4/2022
Elektronische ISSN: 1936-0568
DOI
https://doi.org/10.1007/s12105-022-01473-2

Weitere Artikel der Ausgabe 4/2022

Head and Neck Pathology 4/2022 Zur Ausgabe

Neu im Fachgebiet Pathologie

Assistierter Suizid durch Infusion von Thiopental

Thiopental Originalie

Als Folge des Urteils des Bundesverfassungsgerichts zur Sterbehilfe im Jahr 2020 wurde in den Jahren 2021–2023 eine Reihe (n = 23) von assistierten Suiziden im Landesinstitut für gerichtliche und soziale Medizin Berlin mit jeweils identischen …

Molekularpathologische Untersuchungen im Wandel der Zeit

Open Access Biomarker Leitthema

Um auch an kleinen Gewebeproben zuverlässige und reproduzierbare Ergebnisse zu gewährleisten ist eine strenge Qualitätskontrolle in jedem Schritt des Arbeitsablaufs erforderlich. Eine nicht ordnungsgemäße Prüfung oder Behandlung des …

Vergleichende Pathologie in der onkologischen Forschung

Pathologie Leitthema

Die vergleichende experimentelle Pathologie („comparative experimental pathology“) ist ein Fachbereich an der Schnittstelle von Human- und Veterinärmedizin. Sie widmet sich der vergleichenden Erforschung von Gemeinsamkeiten und Unterschieden von …

Gastrointestinale Stromatumoren

Open Access GIST CME-Artikel

Gastrointestinale Stromatumoren (GIST) stellen seit über 20 Jahren ein Paradigma für die zielgerichtete Therapie mit Tyrosinkinaseinhibitoren dar. Eine elementare Voraussetzung für eine mögliche neoadjuvante oder adjuvante Behandlung bei …